čistí zá&scaron;krtu toxoid, Purifikovaný Tetanový Toxoid, či&scaron;těná pertusového toxoidu, purifikovaný pertussis vláknitý hemaglutinin, hepatitidy B povrchový antigen, Inaktivovaná Polioviru Typu 1 (Mahoney), inaktivovaného polioviru typu 2 (MEF 1), Inaktivovaného Polioviru Typu 3 (Saukett), Haemophilus influenzae typu b polysacharid - Rezultatele cautarii

Uniunea Europeană - română - EMA (European Medicines Agency)

cystadane

recordati rare diseases - betaină anhidră - homocistinuria - alte medicamente pentru tractul digestiv și metabolism, - adjunctive treatment of homocystinuria, involving deficiencies or defects in:cystathionine beta-synthase (cbs);5,10-methylene-tetrahydrofolate reductase (mthfr);cobalamin cofactor metabolism (cbl). cystadane should be used as supplement to other therapies such as vitamin b6 (pyridoxine), vitamin b12 (cobalamin), folate and a specific diet.

Uniunea Europeană - română - EMA (European Medicines Agency)

amversio

serb sa - betaine - homocistinuria - alte medicamente pentru tractul digestiv și metabolism, - amversio is indicated as adjunctive treatment of homocystinuria, involving deficiencies or defects in:• cystathionine beta-synthase (cbs),• 5,10 methylene tetrahydrofolate reductase (mthfr),• cobalamin cofactor metabolism (cbl).

Uniunea Europeană - română - EMA (European Medicines Agency)

epysqli

samsung bioepis nl b.v. - eculizumab - hemoglobinurie, paroxismal - imunosupresoare - epysqli is indicated in adults and children for the treatment of paroxysmal nocturnal haemoglobinuria (pnh). evidence of clinical benefit is demonstrated in patients with haemolysis with clinical symptom(s) indicative of high disease activity, regardless of transfusion history.

Uniunea Europeană - română - EMA (European Medicines Agency)

bekemv

amgen technology (ireland) uc - eculizumab - hemoglobinurie, paroxismal - imunosupresoare - bekemv is indicated in adults and children for the treatment of paroxysmal nocturnal haemoglobinuria (pnh). dovezi de beneficii clinice este demonstrată la pacienții cu hemoliză cu simptom clinic(s) indică un grad înalt de activitate a bolii, indiferent de transfuzie istorie (a se vedea secțiunea 5.